Medical device strategy topics

Medical Device Regulatory Strategy Topics

Compare reference approvals, UDI implementation, and market-entry evidence strategies for medical device manufacturers expanding across FDA, EU, TGA, NMPA, and other regulated markets.

Turn regulatory signals into execution plans

These topics translate approval evidence, identifier systems, local-holder duties, labelling, database submissions, and post-market obligations into practical market-entry decisions.

TopicUS FDA

US FDA Approval as a Multi-Country Medical Device Registration Asset

How 510(k), De Novo, and PMA outcomes can support global medical device filings without replacing local registration.

510(k) / De Novo / PMA

Strong dossier credibility in Canada, parts of LATAM, the Middle East, ASEAN, Australia, Japan, and other mature-regulator-aware markets.

View strategy
TopicEU CE

EU CE Marking under MDR and IVDR as a Global Registration Strategy

How CE technical documentation, clinical evaluation, GSPR, PMS, and notified-body review can support non-EU filings.

MDR / IVDR

Often the most reusable technical-file package for markets using GHTF, IMDRF, CSDT, or EU-aligned evidence structures.

View strategy
TopicMDSAP

MDSAP as a Multi-Country Medical Device QMS Reduction Strategy

How a Medical Device Single Audit Program audit can reduce quality-system audit duplication across participating and accepting markets.

Single QMS audit

Can be a prerequisite, substitute, or strong audit-reliance tool depending on the target country.

View strategy
TopicChina NMPA

China NMPA Approval as an Emerging Global Medical Device Reference Factor

Where an existing China NMPA registration can create formal, partial, supportive, or dossier-reuse value in overseas filings.

China registration / filing

Can help in emerging-market review, distributor due diligence, public procurement, and product-history narratives when the product lacks FDA or CE approval.

View strategy
TopicUDI

Global UDI Compliance Strategy for Medical Device Manufacturers

A practical guide to FDA GUDID, EU Basic UDI-DI and EUDAMED, Australia TGA AusUDID and 2026 Consent to Supply, China NMPA UDID, Saudi-DI, labeling, master data, and enterprise implementation.

UDI master data / labelling / database submission

FDA, EU, TGA, NMPA, and SFDA all use UDI, but their database fields, responsible parties, timing, and change triggers differ.

View strategy
TopicAR / Local Representative

Global Medical Device Authorized Representative / Local Representative Requirements

A global comparison of EU Authorized Representative, UK Responsible Person, US Agent, Australian Sponsor, Japan MAH, Authorized Agent, Registrant, Importer, and Registration Holder roles for foreign medical device manufacturers.

Local representative / registration holder / importer control

Many markets require a local responsibility window before a foreign medical device manufacturer can place devices on the market. The title changes by jurisdiction: EU AR, UKRP, US Agent, Sponsor, MAH/D-MAH, Authorized Agent, Registrant, Licensed Dealer, Importer, or Registration Holder.

View strategy